Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06326905 · ClinicalTrials.gov registry record · NA
CAPABLE Transplant
A NA study of Depression and Quality of Life, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT06326905: Recruiting NA study of Depression and Quality of Life, sponsored by Johns Hopkins University.
NCT06326905 is a NA study of Depression and Quality of Life that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 43 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06326905, a NA study of Depression and Quality of Life, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial, and 3) pilot test the feasibility and acceptability for CAPABLE Transplant in symptom and waitlist specific metrics amongst low-income active kidney transplant waitlist candidates.
Primary Outcome
Death (any cause), Time Inactive Change of waitlist status (inactive to active, delisting)
Conditions Studied
Interventions
- BEHAVIORAL CAPABLE Transplant- Open Label Pilot
- BEHAVIORAL CAPABLE Transplant- Randomized Control Trial
Study Locations (1)
Maryland
- Johns Hopkins School of Nursing - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2025-01-25 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT06326905 shows while recruiting
NCT06326905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which CAPABLE Transplant- Open Label Pilot is the first listed.
NCT06326905 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06326905 about?
NCT06326905 is a clinical study titled "CAPABLE Transplant". The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population...
What is the current status of trial NCT06326905?
This trial is currently recruiting. It is a NA study. The enrollment target is 43 participants. The study started on 2025-01-25. Estimated completion is 2026-07-01.
What conditions does trial NCT06326905 study?
This clinical trial studies the following conditions: Depression, Quality of Life, End Stage Renal Disease, Disability Physical.
What interventions are being tested in trial NCT06326905?
The interventions under investigation include: CAPABLE Transplant- Open Label Pilot (BEHAVIORAL), CAPABLE Transplant- Randomized Control Trial (BEHAVIORAL).
Who is sponsoring clinical trial NCT06326905?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06326905 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06326905's enrollment target sits among peer trials
43 499th of 679 higher than 180 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy